Alerts

The U.S. Senate has passed a bill by unanimous consent to push back the 21% cut for physicians who treat Medicare patients until Nov. 30. Sponsor News Flash: BD announces the release of the shortest and thinnest pen needle available of just 4mm x 32G. BD Ultra-Fine™ Nano Press Release

Medicare to Cut Payments to Physicians on June 15th.

Novo Pulls its Insulins from Greece. See this week’s Item #3.

Type 2 Diabetes Increases Risk of 24 Cancers. See this week’s Item #1. FDA Adds Risk for Severe Liver Injury to Orlistat Label. More information on FDA announcement is available on the agency’s website.

Possible hearing loss with Viagra. Men who took drug twice as likely to report hearing loss, study finds (more information soon). Archives of Otolaryngology-Head and Neck Surgery, May 18, 2010 Glitazone Preserves Beta Cell Function by 70%. See this week’s Item #6. Drinking Soda Linked to Pancreatic Cancer. See this …

Once Weekly Byetta (Bydureon © ) Delayed 6 Months by the FDA: See this week’s Item #14. FDA Orders Recall of Baxter’s Colleague Volumetric Infusion Pumps: The FDA has notified health care professionals and consumers of a letter sent to Baxter on April 30 ordering the company to recall and …

FDA orders recall of Baxter’s Colleague Volumetric Infusion Pumps: The FDA has notified health care professionals and consumers of a letter sent to Baxter on April 30 ordering the company to recall and destroy all Colleague Volumetric Infusion Pumps currently used in the United States — there may be as …

Diabetes Linked to Irregular Heartbeat. See this week’s Item #2. Lilly Submits Reply to FDA Complete Response Letter for BYDUREON™. See this week’s Item #7.  

Experimental Artificial Pancreas Succeeds — See this week’s Item #1. Lilly Submits Reply to FDA Complete Response Letter for BYDUREON™. Response from the FDA is expected within 14 days from April 22, 2010.

FreeStyle Navigator® Continuous Glucose Monitoring System is experiencing a supply interruption and has been unable to provide patients with replacement receivers and transmitters and cannot estimate when the supply of the FreeStyle Navigator Continuous Glucose Monitoring System will resume. The US Food and Drug Administration (FDA) has approved the first …